Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 607

Results For "GE"

7617 News Found

Srichakra receives European Food Safety approval for its food-grade recycled rPET
Sustainability | March 15, 2022

Srichakra receives European Food Safety approval for its food-grade recycled rPET

Srichakra receives European Food Safety approval for its food-grade recycled rPET


Live Pharma Coalition to organise its first-ever conclave in Mumbai
News | March 15, 2022

Live Pharma Coalition to organise its first-ever conclave in Mumbai

The focus is to build collaborative learning and sharing ecosystem


IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
People | March 15, 2022

IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster

He has over 25 years of rich experience in marketing and business in various sectors


AbbVie and Scripps Research plan to develop anti-viral for Covid-19
News | March 15, 2022

AbbVie and Scripps Research plan to develop anti-viral for Covid-19

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


USFDA approves Zydus’ Colestipol Hydrochloride tablets
Drug Approval | March 14, 2022

USFDA approves Zydus’ Colestipol Hydrochloride tablets

It is only the second generic application approved by the USFDA


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


Guardant Health receives regulatory approval for Guardant360 CDx in Japan
Medical Device | March 14, 2022

Guardant Health receives regulatory approval for Guardant360 CDx in Japan

Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers


Corbevax to be administered to children between 12-14 years
News | March 14, 2022

Corbevax to be administered to children between 12-14 years

Govt announces vaccination programme for kids and those above 60 years of age


Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine
News | March 14, 2022

Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine

The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines